Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.

The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...

Although the Zantac settlement resolution announced earlier ... GSK: HIV Presentation Highlights Long-Duration Dosing Options to Help Mitigate 2028 Patent Losses GSK hosted an analyst presentation ...

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...

GSK said total sales fell by two per cent in the third quarter Pharmaceutical giant GSK has reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed guidance and ...

Instead, I remember this: a boy from school who I thought was a friend. I invited him over to my house for a movie. His hand ...

This is a Class II recall, a mid-level designation the FDA uses to communicate how hazardous a recalled product may be to a ...

BioIVT provides Dissociated Tumor Cells from multiple donors for various solid tumor indications. It is important to handle this material as an infectious agent. Necessary precautions should be taken.